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Abstract: Human papillomavirus (HPV) is one of the most prevalent sexually transmitted infections.
Although the research focus has been on women, men are also affected. Thus, the aim was to estimate
the prevalence of HPV in men and to analyse its risk factors. A systematic review with meta-analysis
was performed. The main health science databases were consulted. The search terms were was:
“papilloma virus AND (prevalence OR risk factors) AND men”. The final sample of studies was n =
16 and the men sample for the meta-analysis was n = 18,106. The meta-analysis revealed a prevalence
of 49% (95% Confidence Interval (CI): 35–64%) of any type of human papillomavirus in men and
35% (95% CI: 26–45%) of high-risk human papillomavirus in men. The included studies showed that
stable sexual habits, circumcision and condom use are protective factors against HPV. In addition,
there is a certain positive association with tobacco use and the early initiation of sexual intercourse.
In conclusion, the prevalence of HPV in men is high. The risk factors for HPV infection are sexual
promiscuity, early sexual debut, absence of circumcision, lack of condom use and smoking. Further
study in this field about the effectiveness of the vaccine and health education should be conducted.
Keywords: epidemiology; risk factors; men; papillomavirus; prevalence; health promotion
1. Introduction
Human genital papillomavirus (HPV) is a common sexually transmitted infection (STI) which has
become a major source of morbidity and mortality worldwide [1]. More than 100 types of HPV have
been identified to date. Although most are harmless, about 30 types are associated with an increased
risk of cancer. Those oncogenic HPV are classified as low or high risk subtypes. HPV infections usually
clear without intervention, although low-risk HPV can cause genital warts. In women, high-risk HPV
can provoke cancer in several locations such as the cervix, vulva, vagina and anus. In men, HPV can
lead to cancer of the anus and of the penis [2,3]. Additionally, HPV can also produce cancer in the back
of the throat, as well as the base of the tongue and tonsils (oropharyngeal cancer) [4–6].
Among the low-risk subtypes, the most common serotypes include HPV-6 and HPV-11, which
usually cause benign warts and are occasionally associated with non-invasive lesions. In contrast,
serotypes HPV-16 and HPV-18 are considered high-risk subtypes, due to their high carcinogenic
potential. HPV-16 appears primarily in invasive tumours and in those lesions with a high degree of
malignancy, while HPV-18 is associated with poorly differentiated carcinomas and with increased
lymph node involvement [4,7].
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Most studies of HPV have analysed diagnosis, treatment and prevention in women. Moreover,
strategies in sexual and reproductive health programmes in many countries have focused on
epidemiological control in women, but they have tended to overlook the role of men in this infection,
despite its high prevalence. In fact, it has been suggested that men may constitute a reservoir for
inadvertently transmitting infection to women, due to its asymptomatic nature, thus contributing to
the persistence of infection and cancer [8]. A further consideration is that the few published studies in
this field have reported divergent results.
Several of the risk factors for HPV in men are associated with deficits in hygiene and prevention [9,10].
In fact, HPV vaccines are available against the serotypes, which protect men from most forms of the
disease [11]. Although the HPV vaccine is most effective before the first sexual activity, many sexually
active men aged from 18 to 26 may also benefit from HPV vaccination [12].
In view of the above considerations, this study was undertaken to perform a meta-analysis of
HPV prevalence in men and to analyse the corresponding risk factors. The question that guided this
study was: what is the prevalence of HPV in men and which are its risk factors?
2. Method
2.1. Search Strategy
A systematic review and meta-analysis of the literature was conducted, following the PRISMA [13]
recommendations. The following scientific databases were consulted: PubMed, Scopus, CINAHL,
LILACS, Proquest Health and Medical Collection, Dialnet and SciELO. The following search term was
used, with Medical Subject Headings: “papillomavirus AND (prevalence OR risk factors) AND men”.
The search was conducted in January 2018.
2.2. Inclusion/Exclusion Criteria
The analysis included quantitative studies on HPV in men published in English or Spanish,
unrestricted by year. Studies lacking quantitative statistical information were excluded, as were studies
with mixed samples without independent data on HPV in men, studies that associated HPV with other
diseases, and studies focused on the genetics of the virus.
2.3. Variables and Data Collection
A data collection notebook was used. For longitudinal studies with more than one HPV evaluation,
the first measure obtained in the study population was recorded. The following variables were collected
on the characteristics of the sample: year of publication, country of study, type of publication (article
vs. doctoral thesis) and study design (cross-sectional or longitudinal).
2.4. Selection of Studies, Critical Reading and Level of Evidence
Once the preliminary results obtained from each database, the title and abstract were read.
The full text was then read. After this, a forward and reverse search was carried out within the studies
included to locate as many documents as possible. Finally, the studies were read critically before
the inclusion. The methodological quality was assessed with the checklist proposed by Ciaponni.
The levels of evidence and degree of recommendation used were those proposed by the Oxford Centre
for Evidence-based Medicine [14].
2.5. Data Analysis
Data analysis was performed with the StatsDirect meta-analysis package (version 3, StatsDirect
Ltd., Cambridge, UK). The first step was to perform a sensitivity analysis to ensure that none of the
studies included produced significant changes in outcomes when excluded. Publication bias were then
assessed using Egger’s linear regression test. Prevalence and confidence intervals were calculated by
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random-effects meta-analysis, one for each burnout dimension. The heterogeneity of the sample was
analysed by Cochran’s Q test and the I2 index.
3. Results
In total, 945 relevant studies were located. After reading the titles and abstracts, n = 568 records
were excluded because they were not related to the study topic, the sample also included women, the
study design was not appropriate for this review, or due to the language of publication. After reading
the full texts, the final sample was n = 16 after eliminating duplicates and applying the inclusion and
exclusion criteria. The search and selection process is described in Figure 1. The 37.5% were cohort
studies and 50% were carried out in the United States of America. The characteristics of the studies
and the HPV risk factors are summarized in Table 1.
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Table 1. Characteristic of included studies (n = 16).
Author, Year (Country of
Study) [Reference] Sample Design HPV Risk Factors EL RG
Akogbe et al., 2013 (Brazil,
Mexico and USA) [15]. n = 3909
Cohort
study
Asian/Pacific Islanders had the lowest prevalence of all types of HPV (42.3%) compared to black (66.2%), Mexican (62.3), other (67.3%) and white
races (71.5%).
Asian/Pacific Islanders had the lowest prevalence of oncogenic HPV (18.9%), compared to black (32.2%), whites (31.4%), Mexican (27.5%) and
other (27.1%).
2b B
Auvert et al., 2009
(South Africa) [16]. n = 1264
Clinical
trial Male circumcision protects against high risk-HPV (23.2% prevalence in uncircumcised men against 14% in circumcised men). 2b B
Backes DM et al., 2012
(Kenya) [17]. n = 2509
Clinical
trial
Male circumcision was strongly associated with low probability of flat penile lesions (OR = 0.02) and with higher probability of popular lesions
(OR = 3.0).
Men with flat penile lesions have higher prevalence of the five most common HPV types comparing to men without flat penile lesions.
1a A
Davidson et al., 2014
(South Africa) [18]. n = 128
Cross-
sectional
study
More sexual partners increase prevalence of oral and oropharyngeal HPV prevalence.
No statistically significant differences in HPV prevalence were found regarding age, smoking, alcohol consumption, oral sex, HIV and
clinical lesions.
2c B
Giuliano et al., 2009
(Brazil, México and
USA) [19].
n = 998 Cohortstudy
Statistically significant associations (p < 0.05):
Between 30–34 years, the probability of suffering oncogenic HPV (OR = 1.99) and any type of HPV (OR = 1.81) is higher.
Reduced risk of any type of HPV infection in Asians/Pacific Islands (OR = 0.18) and in mixed races (OR = 0.74).
Reduced risk of oncogenic HPV in Asians/Pacific Islands (OR = 0.32).
Increased risk of oncogenic HPV (OR = 2.18) and of any type of HPV (OR = 2.12) in Brazil.
Higher risk of oncogenic HPV (OR = 2.27) and of any type of HPV (OR = 2.63) in divorced/separated.
Lower risk of oncogenic HPV (OR = 0.70) in non-smokers.
Increased risk of oncogenic HPV (OR = 9.01) and of any type of HPV (OR = 8.15) is related to a greater number of couples.
Lower risk of oncogenic HPV (OR = 0.30) and of any type of HPV (OR = 0.44) if they have not had sex in the last 3 months and Increased risk of
oncogenic HPV (OR = 3.43) and of any type of HPV (OR = 3.05) is related to a greater number of couples in the last 3 months.
Greater risk of oncogenic HPV (OR = 1.45) and of any type of HPV (OR = 1.40) if they have had anal sex.
Lower risk of oncogenic HPV (OR = 0.47) and of any type of HPV (OR = 0.52) if they have never been diagnosed with sexually transmitted disease.
Increased risk of any type of HPV (OR = 1.57) if they have genital herpes.
Increased risk of oncogenic HPV (OR = 2.27) and for any type of HPV (OR = 2.19) if they have had partners with genital warts.
2b B
Hernández et al., 2008
(USA) [20]. n = 351
Cohort
study
Smoking, sex with men, lifetime number of female sex partners, history of genital warts and circumcision are associated with HPV.
History of sex with men was inversely associated with HPV infection of the shaft (OR = 0.44).
Lifetime number of female sex partners was positively associated with HPV infection of the shaft and scrotum (OR = 6.93).
Uncircumcised men have higher prevalence rate of HPV of the glans (OR = 1.96) and oncogenic infection (OR = 2.51).
2b B
Ingles et al., 2015 (USA,
Brazil, México) [21]. n = 2754
Cohort
study High-risk type HPV is more prevalent in penile intraepithelial neoplasia (85.7%) and other genital external lesions (21%) than in condiloma (8.2%). 2b B
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Table 1. Cont.
Author, Year (Country of
Study) [Reference] Sample Design HPV Risk Factors EL RG
King et al., 2015
(England) [22]. n = 511
Cross-
sectional
study
Higher HPV prevalence rate (92.6%) in HIV-positive men who have sex with men compare with HIV-negative men who have sex with men (71.1%).
There is a 4.7% increase in the odd of HPV infection per year when modeling age as a continuous variable (18–40 years). When treating age as a
categorical variable there are no significant differences in HPV infection.
2c B
Leszek et al., 2013
(Poland) [23]. n = 820
Cross-
sectional
study
Higher risk of HVP infection with more than three sexual partners in the last 12 months (OR = 1.44).
HPV infection is greater in men younger than 34 years (OR = 1.08).
Higher HPV infection in men who do not use condoms (OR = 1.86).
2c B
Lu et al., 2009 (USA) [24]. n = 377 Cohortstudy
There is a reduced risk of HPV infection with having a college education or higher (Hazard rate = 0.3) and with older age at first sexual intercourse
(Hazard rate = 0.9).
There is an increased risk of HPV infection in smokers (Hazard rate = 2.4).
2b B
Müller et al., 2016
(South Africa) [25]. n = 200
Cross-
sectional
study
Men with HIV have higher prevalence rate of anal and oropharyngeal HPV.
Men who have sex with men are more likely to have anal HPV than men who have sex with woman (85% vs. 26.8%).
HPV infection is significantly associated with receiving an income, having sex with men only, engaging in group sex in their lifetime, being HIV
positive and practicing receptive anal sex.
2c B
Nielson et al., 2007
(USA) [26]. n = 463
Cross-
sectional
study
Sociodemographic factors are not related to HPV infection.
Smoking is associated with HPV (OR = 1.8).
Smoking 10 or more cigarettes per day is associated with HPV (OR = 3.0).
Using condoms at least half time reduce HPV (OR = 0.5).
Sexual factors such as high number of lifetime female sex partners, female partners on the past 3 months, and an increased frequency of intercourse
in the past month and 3 months are significantly related to HPV.
Current presence of genital warts (OR = 4.5) and having a female parte with abnormal pap smear (OR = 2.2) are related with HPV.
2c B
Quinn et al., 2012
(Peru) [27]. n = 105
Cross-
sectional
study
Being primary receptive as sex role is related with a higher prevalence of HPV, 56%, vs. 4% in insertive.
Having exclusively men as sexual partners is related with higher HPV prevalence (92%) vs. 17.2% when having men and women.
High risk HPV is related to not having a stable relationship, have sex work as primary income and having a greater number of life partners.
2c B
Repp et al., 2012 (Brazil,
Mexico, USA) [28]. n = 2621
Cross-
sectional
study
There are statistically different prevalence rates of any HPV for men that always use condom (65.6%) and men do not always use it (71.9%).
There are statistically different prevalence rates of any oncogenic HPV for men that always use condom (29.6%) and men do not always use it
(35.4%).
2c B
Tarnaud et al., 2011
(South Africa) [29]. n = 3274
Cohort
study
Low risk HPV genotypes significantly increase with the number of lifetime sexual partners.
HIV and Herpes Virus are associated with an increase in low risk HPV genotypes.
Number of low risk HPV genotypes decrease in participants with primary education and those that use condom.
2b B
Vardas et al., 2011
(5 continents) [30]. n = 3463
Cross-
sectional
study
Less condom use is associated with an increased risk of HPV (OR = 1.7).
More than 3 lifetime female sexual partners increase prevalence HPV DNA detection (OR = 4.5).
Africa has the highest risk of HPV (OR = 3.7).
1a A
Note: EL = Evidence level; HPV = Human Papillomavirus; OR = Odd ratio; RG = Recommendation grade; USA = United States of America.
Int. J. Environ. Res. Public Health 2018, 15, 2210 6 of 12
3.1. Meta-Analysis
The meta-analytical estimation of the prevalence of any HPV in males was 49% with a 95%
confidence interval of 35–62%. The forest plot is shown in Figure 2. Regarding the prevalence rate
of high risk HPV the meta-analytical estimation was 35% with a 95% confidence interval of 26–45%.
The forest plot is shown in Figure 3.
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In the heterogeneity analyses of the any HPV meta-analysis, the Cochran Q-value was 3555.24
(p < 0.001) and the I2 index was 99.7%. For the high-risk HPV meta-analysis the Cochran Q-value was
1118.93 (p < 0.001) and the I2 index 99.1%.
The Egger test of publication bias obtained no statistically significant results, p = 0.45 and p = 0.57,
respectively. We conclude, therefore, that our results are not subject to any publication bias. In the
sensitivity analysis, when each of the studies was removed in turn from the sample, the prevalence
values did not change in a statistically significant way.
3.2. HPV and the Initiation of Sexual Relations or Promiscuity
Several studies have reported a strong association between HPV and promiscuous sex [24,26,27].
According to Giuliano [19], the reduced risk of HPV is significantly associated with older age of sexual
initiation; thus, an Odds Ratio (OR) of 0.38 was obtained for any HPV infection among males aged
23–42 compared to those aged ≤13 years. Similarly, Lu et al. [24] reported a lower risk of infection
when the age at first sexual intercourse was older (Hazard Ratio 0.9 [95% CI: 0.8–1.0]) and when there
was a stable partner (OR 0.55–0.58 for non-oncogenic and oncogenic HPV).
A significantly higher risk of HPV detection was associated with an increased number of lifetime
female sexual partners; OR 6.96–9.01 for non-oncogenic HPV (any type) and for oncogenic HPV among
men with ≥50 partners versus only one partner [19]. According to Davidson [18], the association
between HPV and the number of sexual partners is statistically significant (p = 0.027).
Ingles et al. [21] reported that younger men were at higher risk of HPV infection as informed by
Lu et al. [24] and Leszek et al. [23].
3.3. Circumcision
Various studies have shown that circumcision is a protective factor against HPV infection [16,19,20,24].
Hernandez et al. [20] reported that the prevalence of HPV among circumcised men (50%) was lower than
among uncircumcised men (60%). Uncircumcised men had a higher prevalence of HPV infection (46%
vs. 29%, adjusted OR, 1.96 (95% CI: 1.02–3.75) and were at higher risk of oncogenic infection (31% vs.
16%, adjusted OR, 2.51 (95% CI: 1.11–5.69) and risk of infection with multiple types of HPV (31% vs. 12%;
adjusted OR, 3.56 (95% CI: 1.50–8.50) [26].
According to Tarnaud et al. [29], the mechanisms by which circumcised men are less likely to get
infected with HPV may be related to a reduction in the acquisition of new infection or to clarification
of pre-existing infection, since the absence of foreskin may reduce the risk of auto-reinfection at the
urethral site.
Male circumcision is strongly associated with a lower probability of flat penile lesions.
Backes et al. [17] reported that circumcised men were much less likely than uncircumcised men to
have such lesions (0.7% vs. 26.0%, crude OR = 0.02; 95% CI: 0.003–0.1). These authors concluded that
high-risk HPV infection and the high viral load of HPV16/18/31 in the glans were particularly strong
risk factors for flat lesions of the penis.
3.4. Condom Use
Condom use is considered a protective factor against HPV infection [24,28,30]. According to
Nielson et al. [26], consistent condom use is associated with a lower prevalence of HPV. The detection
of HPV DNA at anatomical sites that are not covered by the condom may explain the non-reduction of
HPV prevalence among condom users in the study by Vardas et al. [30].
3.5. Smoking
Several studies have concluded that tobacco use aggravates the risk of HPV infection [24,26].
Current smoking has been associated with a risk of infection by any type of HPV (HR 2.4 [95% CI:
1.3–4.5]) and by non-oncological HPV (HR 2.2 (95% CI: 1.0–4.8]) compared to persons who have never
smoked [24].
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A stronger association was observed between smoking 10 or more cigarettes per day (compared
to smoking 0–9 cigarettes per day) and each of the following outcomes: detection of any HPV (OR 3.0
(95% CI: 1.4–6.4); oncogenic HPV (OR 3.7 (95% CI: 1.6–8.5); and non-oncogenic HPV (OR 2.4 (95% CI:
1.1–5.6]) [26].
3.6. Vaccination
According to King et al. [22], based on evidence of current infection, there is a potential benefit in
vaccinating men against HPV. The results obtained suggest that expanding the use of the tetravalent
vaccine could protect 13–22% men against HPV infection. In addition, it could prevent up to 76%
cases of anal cancer. A study conducted in South Africa concluded that targeted interventions and
HPV vaccination for children should also be considered, in order to reduce the burden of HPV-related
diseases among gay men [25].
3.7. Miscellaneous
Education is considered to be a factor related to HPV infection [24]. University or other higher
education is significantly associated with a lower risk of acquiring new infection, for any type of HPV
(HR 0.3 (95% CI: 0.2–0.7).
According to Ingles et al. [21], genital warts are mainly caused by low-risk types of papillomavirus
such as HPV-6 or HPV-11. Quinn et al. [27] and Müller et al. [25] noted that previous studies had
shown that anal HPV infection is more common among gay men than among heterosexual men with
an anal HPV prevalence being 4–10 times higher among the former.
Akogbe et al. [15] conducted one of the few multinational studies focusing on racial differences
in the prevalence of HPV. In general, the prevalence of any HPV infection (42.3%) and of oncogenic
HPV (18.9%) was lowest among Asians and Pacific Islanders. The absolute differences in prevalence
between the study population (Asian-American and Asian-Brazilian) and reports from Asian countries
may be due to differences in socio-cultural relationships, regarding strict social behaviour, associated
with a conservative, restricted sexuality. This behaviour pattern may have been abandoned by
Asian-Americans as their culture shifted towards that of the United States.
4. Discussion
Due to the association between cervical cancer and HPV, men have not been the focus of HPV
research [31]. Notwithstanding, as shown in the results, the HPV prevalence rates in men are not
low. Some studies inform that HPV vaccination among men is very low and that most of them think
that HPV vaccination is only for females [32]. This, added to the fact that the HPV infection is mostly
subclinical, makes men play an important role in the transmission of the infection to the general
population acting as reservoirs of the disease [32].
Sexual promiscuity, related to the number of sexual partners, in men is an important risk factor
due to multiple sexual contacts facilitate contamination by HPV, which is then transmitted to sexual
partners [33]. When sexual relations are limited to a small number of partners, this greatly reduces the
probability of HPV transmission and therefore the risk of developing cancer. However, the influence of
the sexual network depending on its characteristics (such as prevalence of HPV vaccination, condom
use, sexual promiscuity and age of the first sexual relationship) should also be taken into account
when estimating the risk of HPV. This is especially relevant in women, who are more exposed to HPV
infection, which has been suggested to be directly associated with the development of cancer [10].
Some authors argue that the prevalence of HPV infection is associated with age, and hence with
the pattern of sexual behaviour in the community. Thus, HPV prevalence is greater at earlier ages
(15–25 years) with the initiation of sexual intercourse; later, between 25–40 years of age, there is a
marked decrease, after which the prevalence stabilises [34]. However, the percentage of persistence
among those aged 25–40 years is higher, which implies an increased risk of pre-neoplastic lesions,
due to the above-mentioned trend in this age group [35].
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Regarding prevention, penile circumcision appears to be a protective factor against high-risk
HPV infection. Circumcised men show a lower risk of HPV infection [36]. In uncircumcised men,
the foreskin retracts on the axis during intercourse, and the internal preputial mucous membrane is
exposed to vaginal and cervical fluids. In addition, the intact foreskin is vulnerable during intercourse,
and may facilitate viral entry, with the subpreputial cavity providing a humid environment that
can provide a favourable environment for HPV survival. As a result, circumcision can reduce HPV
exposure and access to epidermal basal cells. In addition, the keratinisation of the circumcision scar
can reduce the risk of HPV infection [36,37].
Condoms present an impermeable barrier to particles the size of the pathogenic microorganisms
of STIs, preventing their transmission and acquisition by avoiding contact between the penis and
genital secretions, the mucous membrane and the skin of the sexual partner. Therefore, condoms are
considered to be a protective factor against HPV infection [38,39].
The tetravalent HPV vaccine provides effective prevention, as shown by the significant decrease
in the rate of immune infection [40]. However, according to researchers, the recent vaccines against
high-risk strains of HPV are prohibitively expensive for many of the poorest countries. On the other
hand, it has been claimed that the protective effects of circumcision may substitute for HPV vaccines
in terms of genotype coverage and target age-group [36].
Smoking is considered to induce added negative effects to HPV infection because cigarette smoke
contains chemicals that damage the genetic structure of the human cells. As a result of this damage
to the DNA, cells turn into oncogenic cells, which accelerates the appearance of genital lesions and
evolution towards cancer [41].
This study has some limitations. First, the number of studies is low because not all the studies
did inform about the prevalence of HPV in men or its risk factors without mixing the data with female
populations or using other diseases as main subjects of the study. Second, the analysis of the risk
factors has been done individually, lacking multivariable analysis. Some variables may influence the
other HPV risk factors, e.g., the educational level has been identified by some authors as a predictor of
condom use, HPV awareness and HPV vaccination in males [42,43]. Finally, although inclusion criteria
were established to find studies with similar populations, a high heterogeneity between studies was
found. It may be explained by the diversity of the countries, with different cultural contexts, where the
studies have been conducted.
5. Conclusions
To our best knowledge, this is the first meta-analysis addressing the prevalence of HPV in the
male population and associated risk factors. We have observed a prevalence of 49% in any HPV
and of 36% in high risk HPV. Stable relationships, circumcision, condom use and non-smoking are
potentially beneficial factors in preventing the development of HPV infection and thus, they should be
given serious consideration. The issue of HPV infection in men warrants further research, particularly
studies aimed at promoting the provision of a vaccine for this population group and educational
campaigns aimed to change sexual behaviour, especially among young men.
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